Automation index

How much of a Foreign-trade technician’s job can AI already do?

An Incoterm comes earlier. The order crossing the border without sticking on the entry do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

28%

AI can already do 28% of this job.

#121 / 623

Foreign-trade technician

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Incoterms, origin and the entry. Estimate No public source provides a precise figure. This is our estimate.	18%	52%	+9.4
Licences, certificates and the missing one. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
The client, the bank and the letter of credit. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Duty, VAT and the customs value. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The forwarder, the delay and not promising the date. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
That it crosses, and not sticking on the entry. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		28%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

23%

#311 / 623

Radiation oncologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Contouring, fractions and the dose plan. Estimate No public source provides a precise figure. This is our estimate.	16%	48%	+7.7
Clinic, the tumour and what can be irradiated. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
Simulation, immobilisation and the machine day. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Side effects, pauses and the patient who cannot take it. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Board, the surgeon and the medical oncologist. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Signing the plan and the dose that does not erase. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		23%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low